• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童双相障碍患者的精神共病 - 系统评价。

Psychiatric comorbidity in patients with pediatric bipolar disorder - A systematic review.

机构信息

Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Centre Copenhagen, Mental Health Services Capital Region, Copenhagen, Denmark.

Child and Adolescent Mental Health Center, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.

出版信息

Acta Psychiatr Scand. 2023 Aug;148(2):110-132. doi: 10.1111/acps.13548. Epub 2023 Mar 28.

DOI:10.1111/acps.13548
PMID:36941106
Abstract

BACKGROUND

A growing body of evidence suggests that pediatric bipolar disorder (PBD) frequently co-occurs with comorbid psychiatric disorders that may impact functioning.

OBJECTIVE

To review existing literature on the prevalence of psychiatric comorbidity and general functioning in patients with a primary diagnosis of PBD.

METHODS

We performed a systematic literature search on the PubMed, Embase and PsycInfo databases on November 16th, 2022. We included original papers on patients ≤18 years with primary PBD and any comorbid psychiatric disorder, diagnosed according to a validated diagnostic tool. Risk of bias of the individual studies was assessed using the STROBE checklist. We calculated weighted means to assess the comorbidity prevalence. The review complied with PRISMA statement guidelines.

RESULTS

Twenty studies with a total study population of 2722 patients with PBD were included (mean age = 12.2 years). We found an overall high prevalence of comorbidity in patients with PBD. The most common comorbidities were attention-deficit-hyperactivity disorder (ADHD) (60%) and oppositional defiant disorder (ODD) (47%). Anxiety disorders, obsessive-compulsive disorder, conduct disorder, tic disorders and substance-related disorders affected between 13.2% and 29% of patients, while one in 10 had comorbid mental retardation or autism spectrum disorder (ASD). The prevalence of comorbid disorders was lower in studies that assessed the current prevalence in patients in full or partial remission. General functioning was overall not specifically decreased in patients with comorbidity.

CONCLUSIONS

Comorbidity across a broad range of disorders was high in children diagnosed with PBD, especially regarding ADHD, ASD, behavioral and anxiety disorders including OCD. Future original studies should assess current prevalence of comorbidities in patients with PBD who are in remission to obtain more reliable estimates of psychiatric comorbidity in this patient group. The review highlights the clinical and scientific importance of comorbidity in PBD.

摘要

背景

越来越多的证据表明,儿童双相情感障碍(PBD)常与合并的精神疾病共病,这可能会影响其功能。

目的

综述原发性 PBD 患者合并精神疾病和一般功能的现有文献。

方法

我们于 2022 年 11 月 16 日在 PubMed、Embase 和 PsycInfo 数据库中进行了系统文献检索。我们纳入了符合以下标准的原始论文:≤18 岁的患者,有原发性 PBD 和任何合并的精神疾病,根据经过验证的诊断工具进行诊断。使用 STROBE 清单评估个体研究的偏倚风险。我们计算了加权均值来评估合并症的患病率。该综述符合 PRISMA 声明指南。

结果

纳入了 20 项研究,共有 2722 例 PBD 患者,(平均年龄为 12.2 岁)。我们发现 PBD 患者合并症的总体患病率较高。最常见的合并症是注意力缺陷多动障碍(ADHD)(60%)和对立违抗性障碍(ODD)(47%)。焦虑障碍、强迫症、品行障碍、抽动障碍和物质相关障碍的患病率在 13.2%至 29%之间,而 10%的患者有合并智力障碍或自闭症谱系障碍(ASD)。在评估完全或部分缓解患者当前患病率的研究中,合并症的患病率较低。总体而言,合并症患者的一般功能并未明显下降。

结论

在被诊断为 PBD 的儿童中,广泛的疾病共病率较高,尤其是 ADHD、ASD、行为和焦虑障碍,包括强迫症。未来的原始研究应评估处于缓解期的 PBD 患者的合并症当前患病率,以获得该患者群体中合并症更可靠的估计。该综述强调了 PBD 中合并症的临床和科学重要性。

相似文献

1
Psychiatric comorbidity in patients with pediatric bipolar disorder - A systematic review.儿童双相障碍患者的精神共病 - 系统评价。
Acta Psychiatr Scand. 2023 Aug;148(2):110-132. doi: 10.1111/acps.13548. Epub 2023 Mar 28.
2
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
3
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
4
Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).针对自闭症谱系障碍(ASD)个体的强迫症(OCD)的行为和认知行为疗法。
Cochrane Database Syst Rev. 2021 Sep 3;9(9):CD013173. doi: 10.1002/14651858.CD013173.pub2.
5
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2012 Sep 12(9):CD008559. doi: 10.1002/14651858.CD008559.pub2.
6
Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.自闭症谱系障碍和注意力缺陷多动障碍儿童及青少年的医学合并症:一项系统综述。
Eur Child Adolesc Psychiatry. 2017 Sep;26(9):1093-1103. doi: 10.1007/s00787-017-1020-0. Epub 2017 Jul 3.
7
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).自闭症谱系障碍(ASD)中易怒、攻击行为和自我伤害的药物干预。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.
8
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.
9
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
10
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.

引用本文的文献

1
Understanding Pediatric Bipolar Disorder Through the Investigation of Clinical, Neuroanatomic, Neurophysiological and Neurocognitive Dimensions: A Pilot Study.通过临床、神经解剖学、神经生理学和神经认知维度研究理解儿童双相情感障碍:一项初步研究。
Brain Sci. 2025 Feb 3;15(2):152. doi: 10.3390/brainsci15020152.
2
Pediatric Bipolar Disorder: Challenges in Diagnosis and Treatment.小儿双相情感障碍:诊断与治疗中的挑战
Paediatr Drugs. 2025 Mar;27(2):125-142. doi: 10.1007/s40272-024-00669-z. Epub 2024 Nov 27.
3
Sleep quality predicts future mood symptoms in adolescents with bipolar disorder.
睡眠质量可预测双相情感障碍青少年未来的情绪症状。
J Affect Disord. 2024 Sep 15;361:664-673. doi: 10.1016/j.jad.2024.06.069. Epub 2024 Jun 23.
4
Does Screening for Bipolar Disorders Identify a "Dysregulation of Mood, Energy, and Social Rhythms Syndrome" (DYMERS)? A Heuristic Working Hypothesis.双相情感障碍筛查能否识别出“情绪、精力和社交节律失调综合征”(DYMERS)?一个启发式工作假设。
J Clin Med. 2023 Aug 7;12(15):5162. doi: 10.3390/jcm12155162.
5
Comorbidity in pediatric bipolar disorder: An unmet challenge in need of treatment studies.儿童双相情感障碍中的共病:一项亟需治疗研究的未解决挑战。
Acta Psychiatr Scand. 2023 Aug;148(2):107-109. doi: 10.1111/acps.13591.